Breaking News Instant updates and real-time market news.

PSEC

Prospect Capital

$6.94

(0.00%)

, YPF

YPF

$14.90

(0.00%)

09:40
08/20/18
08/20
09:40
08/20/18
09:40

Unusually active option classes on open August 20th

Unusual total active option classes on open include: Prospect Capital (PSEC), YPF (YPF), United Rentals (URI), ProShares UltraShort Lehman 20 plus Year Treasury (TBT), Zillow (Z), Direxion Junior Gold (JNUG), Home Depot (HD), Teva (TEVA), Energy Sector SPDR ETF (XLE), and Tesla (TSLA).

PSEC

Prospect Capital

$6.94

(0.00%)

YPF

YPF

$14.90

(0.00%)

URI

United Rentals

$150.48

(0.00%)

TBT

ProShares UltraShort 20+ yr Trsry

$36.15

(0.00%)

Z

Zillow

$46.28

(0.00%)

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$7.81

(0.00%)

HD

Home Depot

$195.61

(0.00%)

TEVA

Teva

$24.21

(0.00%)

XLE

Energy Select Sector SPDR

$72.63

(0.00%)

TSLA

Tesla

$305.33

(0.00%)

  • 10

    Sep

  • 12

    Sep

  • 16

    Sep

  • 29

    Oct

PSEC Prospect Capital
$6.94

(0.00%)

08/30/17
08/30/17
UPGRADE

Market Perform
Prospect Capital upgraded to Market Perform at Raymond James
As previously reported, Raymond James upgraded Prospect Capital to Market Perform from Underperform. Analyst Robert Dodd expects near-term earnings will cover the lower dividend run-rate but notes downside risk remains.
08/30/17
RAJA
08/30/17
UPGRADE
RAJA
Market Perform
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
08/30/17
08/30/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Sanofi (SNY) upgraded to Hold from Reduce at HSBC, with analyst Steve McGarry citing valuation. 2. M.D.C. Holdings (MDC) upgraded to Market Perform from Underperform at Wells Fargo with analyst Stephen East saying he sees "little reason the equity would move meaningfully lower" from current levels. 3. Ciena (CIEN) upgraded to Buy from Neutral at Citi with analyst Stanley Kovler saying the risk/reward is positive into third quarter results. 4. Six Flags (SIX) upgraded to Buy from Neutral at Hilliard Lyons with analyst Jeff Thomison citing improved valuation based on its 13% year-to-date pullback. 5. Prospect Capital (PSEC) upgraded to Market Perform from Underperform at Raymond James with analyst Robert Dodd saying he expects near-term earnings will cover the lower dividend run-rate but notes downside risk remains. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
YPF YPF
$14.90

(0.00%)

06/27/18
UBSW
06/27/18
DOWNGRADE
UBSW
Neutral
YPF downgraded to Neutral from Buy at UBS
04/23/18
04/23/18
UPGRADE
Target $28

Strong Buy
YPF upgraded to Strong Buy on valuation at Raymond James
As previously reported, Raymond James upgraded YPF to Strong Buy from Outperform and maintained a $28 price target. Analyst Pavel Molchanov said shares are trading near the lowest of the global integrated universe and the ongoing ramp in the Vaca Muerta shale play, an underappreciated source of optionality , should drive meaningful multiple expansion.
04/23/18
RAJA
04/23/18
UPGRADE
RAJA
Strong Buy
YPF upgraded to Strong Buy from Outperform at Raymond James
02/20/18
JPMS
02/20/18
DOWNGRADE
Target $12
JPMS
Underweight
Ecopetrol downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Rodolfo Angele yesterday downgraded Ecopetrol (EC) to Underweight while raising his price target for the shares to $12 from $9.30. The analyst views the recent rally in the stock as overdone. He prefers shares of YPF (YPF) and Petrobras (PBR) to Ecopetrol.
URI United Rentals
$150.48

(0.00%)

07/13/18
UBSW
07/13/18
NO CHANGE
Target $196
UBSW
Buy
United Rentals looks attractive after selloff, says UBS
UBS analyst Steven Fisher believes the selloff in United Rentals shares following the company's Q1 earnings report has been overdone and he sees the shares as attractive ahead of its Q2 report given his expectations for continued end market strength and improved margins. He also expects the company to make additional deals over the next 18 months. Fisher reiterates a Buy rating and $196 price target on United Rentals shares.
07/13/18
BUCK
07/13/18
UPGRADE
BUCK
Buy
United Rentals upgraded to Buy from Neutral at Buckingham
08/14/18
UBSW
08/14/18
NO CHANGE
Target $196
UBSW
Buy
United Rentals business activity remains healthy, says UBS
UBS analyst Steven Fisher met with United Rental management and noted business demand remains healthy with sales up in 44 of 49 states and up in all provinces and verticals. The analyst sees no sign of any downturn developing and refutes any peak business concerns. Fisher reiterated his Buy rating and $196 price target on United Rentals shares.
07/13/18
07/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. VF Corp. (VFC) upgraded two notches to Buy from Underperform at BofA/Merrill with analyst Robert Ohmes saying he believes Vans momentum is sustainable and will be a "go-to-brand" for the back-to-school selling season. 2. United Rentals (URI) and Herc Holdings (HRI) were upgraded to Buy from Neutral at Buckingham. 3. Raymond James (RJF) upgraded to Buy from Neutral at Citi with analyst William Katz saying he still prefers alternative managers. 4. M.D.C. Holdings (MDC) upgraded to Neutral from Underweight at JPMorgan with analyst Michael Rehaut saying the current valuation appropriately reflects his outlook for above average order growth and margin expansion in 2018. 5. BlackRock (BLK) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Robert Lee saying shares deserve a premium valuation given its strong secular position and views the recent sell-off as a buying opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
TBT ProShares UltraShort 20+ yr Trsry
$36.15

(0.00%)

Z Zillow
$46.28

(0.00%)

08/07/18
SPHN
08/07/18
NO CHANGE
Target $62
SPHN
Overweight
Zillow 'hiccups' provide buying opportunity, says Stephens
Stephens analyst John Campbell said Zillow's (ZG) core business continues to perform nicely despite the early growing pains seen in its new Homes business. He sees "some hiccups" triggering the guidance decrease and remains highly upbeat on Zillow over the long-term, recommending that investors use the weakness as a buying opportunity. He lowered his price target on the stock to $62 from $64 but maintains an Overweight rating on Zillow, whose Class A shares are down $9.50, or 16%, to $49.50 in pre-market trading.
08/07/18
BWSF
08/07/18
NO CHANGE
Target $194
BWSF
Sell
Zillow acquisition a risk for LendingTree, says BWS Financial
The acquisition of Mortgage Lenders of America by Zillow Group (ZG) is further risk to LendingTree's (TREE) business, BWS Financial analyst Hamed Khorsand tells investors in a research note. LendingTree is already facing a price ceiling on referral rates, the analyst contends. He believes Zillow buying one of the company's customers "emphasizes some of the headwinds that could persist for a while." Further consolidation among mortgage lenders could further deteriorate the ability for LendingTree to retain current level of referral rates, Khorsand contends. He keeps a Sell rating on the shares with a $194 price target.
08/07/18
08/07/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Zillow (Z, ZG) downgraded to Neutral from Buy at BofA/Merrill with analyst Nat Schindler saying the quarter indicated Zillow is taking longer than expected to ramp up the Homes business, Rentals revenue missed and the outlook cut, and other revenue also missed, indicating new construction opportunity is also taking longer to materialize. 2. CBS (CBS) downgraded to Hold from Buy at Argus with analyst Joseph Bonner citing significant downside risks for the company from both the sexual harassment allegations against CEO Moonves and the board's attempts to prevent the Viacom (VIAB) merger. 3. Extraction Oil & Gas (XOG) downgraded to Neutral from Outperform at Macquarie with analyst Paul Grigel citing increased risk from Colorado Initiative 97. 4. Wynn Resorts (WYNN) downgraded to Hold from Buy at Argus with analyst John Staszak citing its Q2 earnings miss, saying the gross gaming revenue in Macau has now missed consensus forecasts for the months of June and July. 5. Dentsply Sirona (XRAY) downgraded to Neutral from Outperform at Baird. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/07/18
08/07/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BOFA CUTS ZILLOW TO NEUTRAL: BofA Merrill Lynch analyst Nat Schindler downgraded Zillow (Z, ZG) to Neutral from Buy and cut its price target to $60 from $70 following the Q2 report and reduction in guidance. Schindler said the quarter indicated Zillow is taking longer than expected to ramp up the Homes business, Rentals revenue missed and the outlook was cut, and other revenue also missed, indicating the new construction opportunity is also taking longer to materialize. Zillow Class A shares are down about 17% in late morning trading. MORGAN STANLEY SAYS WAYMO COULD BE WORTH $175B: Morgan Stanley analyst Brian Nowak increased his enterprise value estimate for Alphabet's (GOOG, GOOGL) Waymo unit from $75B for ride sharing only to $175B given his analyses for two other emerging business models, logistics and licensing. He believes Waymo remains on track to launch an autonomous ride hailing service in Phoenix this year and believes this business could be worth about $80B over the long-term. Given his view of Waymo being a key part of Alphabet's long-term value, Nowak raised his sum of the parts valuation to $1,550 from $1,400. He has an Overweight rating and $1,325 price target on Alphabet shares. GOLDMAN RAISES NVIDIA TARGET AHEAD OF EARNINGS: Goldman Sachs analyst Toshiya Hari raised his price target for Nvidia (NVDA) to $324 from $310 ahead of quarterly results. Unlike the past 10 quarters where the company handily beat Street estimates and raised guidance, the analyst expects a "noisy" quarter with the focal points being the upcoming product transition in Gaming, the current product transition in Datacenter, weakness in cryptocurrency mining, and potential disruption from the virus attack at TSMC (TSM). That said, Hari noted that his long-term bull thesis on Nvidia remains intact and reiterated a Buy rating on the shares. ARGUS CUTS CBS TO HOLD: Argus analyst Joseph Bonner downgraded CBS (CBS) to Hold from Buy, noting significant downside risks for the company from both the sexual harassment allegations against CEO Moonves and the board's attempts to prevent the Viacom (VIA, VIAB) merger. Bonner noted that if the Moonves allegations are proven true, he would be immediately dismissed, which could end the board's bid to remain independent and thereby inflict damage on the shareholders.
JNUG Direxion Daily Jr Gld Mnrs Bull 3X Shrs
$7.81

(0.00%)

HD Home Depot
$195.61

(0.00%)

08/20/18
UBSW
08/20/18
NO CHANGE
Target $115
UBSW
Buy
Lowe's could lower guidance following Q2 results, says UBS
UBS analyst Michael Lasser said Lowe's (LOW) has underperformed versus Home Depot (HD) over the past decade due to its lower labor productivity, lower Pro and online penetration, higher cost structure, and lower inventory per SKU. He believes the earnings conference call could touch on some of these subjects, but also believes management could lower full-year 2018 guidance to give themselves breathing room on expectations. Lasser maintained his Buy rating and $115 price target on Lowe's shares.
08/15/18
JPMS
08/15/18
NO CHANGE
Target $223
JPMS
Overweight
Home Depot shares could climb 'wall of worry' in 2H, says JPMorgan
JPMorgan analyst Christopher Horvers maintained an Overweight rating and $223 price target on Home Depot shares, noting to investors in a research note that despite "nice" upside to comps in Q2, the stock traded slightly lower. Horvers says he continues to believe concerns on the cycle remain a near-term overhang on the stock, and expects shares will climb the "cycle wall of worry" in the second half of the year as Home Depot likely posts upside to sales driven by market growth rate and share capture. He expects the stock will re-rate higher as investors gain comfort with 2019 forecasts.
08/15/18
STFL
08/15/18
NO CHANGE
Target $225
STFL
Buy
Stifel sees 'no reason' to be concerned about Home Depot in near-term
Stifel analyst John Baugh said that a slowdown in housing is increasingly a concern for Home Depot investors, but also noted that management doesn't believe it is impacting results as housing turnover only represents about 5% of total sales now. Baugh believes there is "no reason to be concerned" in the near-term as he thinks investments can fuel future growth. While he is "definitely keeping an eye on things more closely," Baugh said that he sees signs that point to remodeling spending strength into next year at least and he keeps a $225 price target and Buy rating on Home Depot shares.
08/15/18
SBSH
08/15/18
NO CHANGE
SBSH
Buy
Home Depot hinted that second half guidance could be conservative, says Citi
Citi analyst Kate McShane noted that Home Depot's comp growth is likely to slow in the second half as the company laps the benefit from late-2017 hurricanes, but she believes the company's initiatives should still support mid-single digit growth. She also said that management hinted on its earnings call that its second half guidance could prove conservative given the solid macro backdrop, which they still sees as supportive of the home improvement industry. McShane keeps a Buy rating on Home Depot shares.
TEVA Teva
$24.21

(0.00%)

08/08/18
FBCO
08/08/18
NO CHANGE
FBCO
Credit Suisse remains cautiously optimistic on Teva's Fremanezumab approval
Credit Suisse analyst Vamil Divan believes Celltrion press releases and Teva's comments still point to September approval for Fremabezumab. While the analyst would certainly prefer a cleaner story heading into the Action Date, he is comfortable enough with the company comments to maintain a cautiously optimistic view.
08/17/18
HCWC
08/17/18
NO CHANGE
Target $4.5
HCWC
Buy
H.C. Wainwright ups Antares price target to $4.50 after generic EpiPen approval
After the FDA announced the "long-awaited" approval of Antares Pharma (ATRS) and partner Teva's (TEVA) generic EpiPen, H.C. Wainwright analyst Oren Livnat said his estimates include nearly $40M in peak EpiPen revenue to Antares from the "biggest partnered pipeline opportunity" the company has modeled by his and consensus estimates. Livnat, who said he is not aware of any other substitutable EpiPen generics on the way, views the product as a sustainable contributor and raised his price target on Antares shares to $4.50 from $4.00 following the news. Livnat, who assumes Teva launches quickly after final label packaging, but believes that Teva "unfortunately" will miss the big EpiPen back-to-school prescribing season, keeps a Buy rating on Antares shares.
08/16/18
WELS
08/16/18
NO CHANGE
WELS
Market Perform
Teva's earlier than expected generic EpiPen bad news for Mylan, says Wells Fargo
Wells Fargo analyst David Maris said he believes the EpiPen generic seemed to have been thought of as a 2019 event by Mylan (MYL) and Teva (TEVA) investors, so the FDA approval today of the first generic EpiPen came earlier than expectations, which is both good news for Teva and negative news for Mylan. Mylan no longer breaks out the Specialty segment, so it is difficult to estimate how meaningful this is to the company, said Maris, but he believes "this is still an important product to Mylan." He keeps a Market Perform rating on Mylan shares, and for Teva calls the approval "a great addition for a company in need of good news."
08/16/18
PIPR
08/16/18
NO CHANGE
Target $450
PIPR
Overweight
Regeneron's fasinumab safety remains 'open question,' says Piper Jaffray
Piper Jaffray analyst Christopher Raymond backed an Overweight rating on Regeneron Pharmaceuticals (REGN) shares following this morning's release of fasinumab results, saying the drug and partner Teva's (TEVA) anti-NGF antibody met its primary and secondary efficacy pain and functional endpoints in a Phase 3 trial of patients with chronic pain from osteoarthritis of the knee or hip. Raymond says the efficacy "was never really in doubt," but the bigger focus for the drug is safety, and will wait for detailed data at an upcoming medical meeting, but notes that fasinumab's arthropathy rate appears "slightly higher" than that of tanezumab. Given the severity of the ongoing opioid epidemic and relative lack of alternatives for these patients outside of total joint replacement, the analyst thinks the appetite of regulators and potential market for new effective, non-opioid chronic pain therapies like anti-NGF clearly exists, though he will leave this as an unmodeled potential source of upside for now,
XLE Energy Select Sector SPDR
$72.63

(0.00%)

10/03/17
MSCO
10/03/17
NO CHANGE
MSCO
Energy sector upgraded to 'Attractive' at Morgan Stanley
Morgan Stanley analysts led by Martijn Rats upgraded the Energy sector to "Attractive," saying they see increasingly clear signs that oil prices and production costs are near to finding a new equilibrium and that the sector's 6-year bear market is set to come to an end. Oil demand continues to grow well above historical trend rates and the downstream outlook is "outright strong," the team tells investors. In developed markets, the best positioned to benefit are downstream focused firms and high yielding majors, such as Shell (RDS.A), BP (BP) and Repsol (REPYY), the analysts said.
TSLA Tesla
$305.33

(0.00%)

08/16/18
EVER
08/16/18
NO CHANGE
Target $301
EVER
In Line
After visiting Tesla's Freemont facility, Evercore ISI says Model 3 'on track'
Evercore ISI analyst George Galliers said he is a bit more positive on Tesla following his trip to the company's Freemont facility, stating that Tesla "seems well on the way" to achieving steady production of 5,000 to 6,000 Model 3 units per week and that reaching 7,000 to 8,000 units per week seems "well within reach." Following the trip, he said the Model 3 looks to be "on track" and while he continues to forecast second half Model 3 production of 123,000 units, Galliers now believes his estimate could be 4%-7% too low. He maintains an In Line rating on Tesla shares with a $301 price target.
08/16/18
BERN
08/16/18
NO CHANGE
Target $325
BERN
Tesla price target raised to $325 after 'taking company private' tweet at Bernstein
Bernstein analyst A.M. Sacconaghi, Jr. raised his price target for Tesla to $325 after Elon Musk shocked investors last week when he tweeted that he was considering a take-private transaction for Tesla at $420 per share, and given the fact that it has been over a year since the analyst last adjusted his price target. Sacconaghi sees the odds of a successful take-private transaction at less than 50%, with downside to about $300 and upside to approximately $400.
08/15/18
VERT
08/15/18
NO CHANGE
VERT
Sell
Goldman involvement with Tesla 'doesn't mean anything,' says Vertical Research
Vertical Research analyst Gordon Johnson said Goldman Sachs (GS) being confirmed as a financial advisor to Tesla's (TSLA) proposed go-private offer "does not mean anything" beyond the "superficial optics" of the carmaker being able to "use Goldman's prestigious name to lend credence to the deal." Goldman is "in it for M&A fees" and agreeing to be an advisor is "not based on any inherent understanding of Tesla's value proposition, nor is it based on Goldman's confidence in Tesla's legal situation with respect to its significant issues surrounding disclosures and SEC involvement," according to Johnson, who maintains a Sell rating on Tesla shares.

TODAY'S FREE FLY STORIES

GOLD

Barrick Gold

$12.12

-0.07 (-0.57%)

19:18
05/21/19
05/21
19:18
05/21/19
19:18
Hot Stocks
Barrick says Acacia proposal reflects 'fair value' following Tanzania talks »

Barrick Gold Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SE

Sea Limited

$25.38

-0.42 (-1.63%)

19:04
05/21/19
05/21
19:04
05/21/19
19:04
Hot Stocks
Sea Limited reports Q1 QAUs up 114.4% from last year »

Reports Q1 Quarterly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

SE

Sea Limited

$25.38

-0.42 (-1.63%)

19:02
05/21/19
05/21
19:02
05/21/19
19:02
Earnings
Sea Limited reports Q1 EPS (64c), consensus (68c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

SNE

Sony

$51.01

-1.195 (-2.29%)

18:48
05/21/19
05/21
18:48
05/21/19
18:48
Periodicals
Sony aims to bolster cash flow to better compete in chips, games, NAR says »

Sony is seeking to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jun

OOMA

Ooma

$14.49

-0.45 (-3.01%)

, CVI

CVR Energy

$47.29

0.9 (1.94%)

18:47
05/21/19
05/21
18:47
05/21/19
18:47
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Ooma…

OOMA

Ooma

$14.49

-0.45 (-3.01%)

CVI

CVR Energy

$47.29

0.9 (1.94%)

PVH

PVH Corp.

$108.53

2.5075 (2.37%)

PSTG

Pure Storage

$20.60

0.6 (3.00%)

JWN

Nordstrom

$37.88

0.42 (1.12%)

URBN

Urban Outfitters

$27.01

0.05 (0.19%)

TOL

Toll Brothers

$38.34

0.82 (2.19%)

ONCS

OncoSec

$3.95

0.149 (3.92%)

EKSO

Ekso Bionics

$1.84

-0.06 (-3.16%)

TOCA

Tocagen

$8.81

-0.18 (-2.00%)

LIQT

LiqTech

$9.29

-0.21 (-2.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 23

    May

  • 28

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 03

    Jun

  • 04

    Jun

  • 05

    Jun

  • 06

    Jun

  • 10

    Jun

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 09

    Jul

  • 22

    May

  • 22

    May

  • 22

    May

TREX

Trex Company

$61.44

2.38 (4.03%)

18:45
05/21/19
05/21
18:45
05/21/19
18:45
Hot Stocks
Trex Company CEO: There is no demand issue »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

CRMT

America's Car-Mart

$101.76

1.74 (1.74%)

18:34
05/21/19
05/21
18:34
05/21/19
18:34
Earnings
America's Car-Mart reports Q4 EPS $2.07, consensus $1.82 »

Reports Q4 revenue $177M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 30

    May

  • 13

    Nov

JCOM

j2 Global

$87.23

0.75 (0.87%)

18:25
05/21/19
05/21
18:25
05/21/19
18:25
Hot Stocks
j2 Global CFO sells 5.6K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 22

    May

  • 05

    Jun

NVS

Novartis

$82.38

0.36 (0.44%)

18:24
05/21/19
05/21
18:24
05/21/19
18:24
Hot Stocks
Novartis CEO: We are entering an exciting growth phase for the company »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 31

    May

EADSY

Airbus

$0.00

(0.00%)

18:20
05/21/19
05/21
18:20
05/21/19
18:20
Periodicals
Airbus in talks to find resolution to German arms export row, Reuters says »

Airbus CEO Guillaume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGRO

Adecogro

$6.50

0.07 (1.09%)

18:19
05/21/19
05/21
18:19
05/21/19
18:19
Earnings
Adecogro reports Q1 adjusted EBITDA $58.3M, down 5.9% from last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,149.14

10.81 (0.95%)

, GOOGL

Alphabet Class A

$1,154.26

8.98 (0.78%)

18:01
05/21/19
05/21
18:01
05/21/19
18:01
Hot Stocks
Google updates policy on abortion-related ads »

Google said in a post…

GOOG

Alphabet

$1,149.14

10.81 (0.95%)

GOOGL

Alphabet Class A

$1,154.26

8.98 (0.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 27

    Oct

HAIN

Hain Celestial

$23.90

0.45 (1.92%)

17:50
05/21/19
05/21
17:50
05/21/19
17:50
Hot Stocks
Engaged Capital raises stake in Hain Celestial to 20.2% from 18.3% »

Engaged Capital raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTDOY

Nintendo

$0.00

(0.00%)

17:48
05/21/19
05/21
17:48
05/21/19
17:48
Hot Stocks
Nintendo to end 'Animal Crossing,' 'Fire Emblem' mobile game service in Belgium »

Nintendo announced that,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jun

  • 11

    Jun

URBN

Urban Outfitters

$27.01

0.05 (0.19%)

17:44
05/21/19
05/21
17:44
05/21/19
17:44
Hot Stocks
Urban Outfitters sees Q2 URBN retail SSS in low single-digit negative range »

Says guidance based on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 04

    Jun

GLD

SPDR Gold Shares

$120.34

-0.31 (-0.26%)

17:42
05/21/19
05/21
17:42
05/21/19
17:42
Hot Stocks
SPDR Gold Shares holdings rise to 739.69MT from 736.17MT »

This is the highest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASCMA

Ascent Capital

$0.91

0.0502 (5.87%)

17:38
05/21/19
05/21
17:38
05/21/19
17:38
Hot Stocks
Ascent Capital and Monitronics International announce restructuring support pact »

Ascent Capital Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRS

TriMas

$30.33

0.39 (1.30%)

17:33
05/21/19
05/21
17:33
05/21/19
17:33
Hot Stocks
TriMas VP Joshua Sherbin sells over $646K in company shares »

TriMas VP Joshua Sherbin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUNW

Sunworks

$0.71

-0.1024 (-12.65%)

17:33
05/21/19
05/21
17:33
05/21/19
17:33
Syndicate
Breaking Syndicate news story on Sunworks »

Sunworks files $50M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LFUS

Littelfuse

$170.78

1.7 (1.01%)

, SMTC

Semtech

$44.74

0.36 (0.81%)

17:32
05/21/19
05/21
17:32
05/21/19
17:32
Initiation
Littelfuse, Semtech, CTS Corporation, Vishay initiated  »

Cowen initiates discrete…

LFUS

Littelfuse

$170.78

1.7 (1.01%)

SMTC

Semtech

$44.74

0.36 (0.81%)

CTS

CTS Corporation

$27.91

0.33 (1.20%)

VSH

Vishay

$16.43

0.37 (2.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 13

    Jun

  • 27

    Jun

GVA

Granite Construction

$41.46

0.5 (1.22%)

17:31
05/21/19
05/21
17:31
05/21/19
17:31
Hot Stocks
Granite Construction awarded $505M high speed rail contract »

Granite announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

OMC

Omnicom

$80.09

0.69 (0.87%)

17:30
05/21/19
05/21
17:30
05/21/19
17:30
Syndicate
Breaking Syndicate news story on Omnicom »

Omnicom files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTEC

TTEC Holdings

$38.68

0.51 (1.34%)

17:26
05/21/19
05/21
17:26
05/21/19
17:26
Hot Stocks
TTEC Holdings EVP DeGhetto sells 35K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 10

    Jun

  • 11

    Jun

  • 12

    Jun

  • 16

    Jun

TDW

Tidewater

$24.80

0.31 (1.27%)

17:25
05/21/19
05/21
17:25
05/21/19
17:25
Hot Stocks
Tidewater director Dick Fagerstal purchases almost $107K shares of company stock »

Tidewater director Dick…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

PTCT

PTC Therapeutics

$40.07

2.67 (7.14%)

17:16
05/21/19
05/21
17:16
05/21/19
17:16
Hot Stocks
Point72 Asset Management takes 5.0% passive stake in PTC Therapeutics »

Point72 Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 31

    May

  • 12

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.